APA (7th ed.) Citation

JW, H., J, S., NV, C., M, D., LP, G., EC, M., . . . L, S. (2010). Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report-Part I. Value in Health, 13(1), 3. https://doi.org/10.1111/j.1524-4733.2009.00663.x

Chicago Style (17th ed.) Citation

JW, Hay, et al. "Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report-Part I." Value in Health 13, no. 1 (2010): 3. https://doi.org/10.1111/j.1524-4733.2009.00663.x.

MLA (9th ed.) Citation

JW, Hay, et al. "Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report-Part I." Value in Health, vol. 13, no. 1, 2010, p. 3, https://doi.org/10.1111/j.1524-4733.2009.00663.x.